Birdwatch Note Rating
2023-07-01 19:09:09 UTC - HELPFUL
Rated by Participant: A20C37164E1ABD6DFC59D3804A6E8E682B9E85177B5919B3497E4D17A4B33657
Participant Details
Original Note:
Ketamine, an anesthetic used for many years, was sanctioned by the FDA in 2019 as a nasal spray for individuals suffering from depression that has been resistant to other treatments. Studies have shown it to be as effective as ECT at treating depression. Harvard Health https://www.health.harvard.edu/blog/ketamine-for-treatment-resistant-depression-when-and-where-is-it-safe-202208092797
All Note Details